In this free webinar, learn about delivering stronger evidence in clinical trials for depression. Attendees will learn how to navigate diversity versus homogeneity in recruitment. The featured speakers will discuss the benefits of remote participation for patients with depression, including ways to incorporate sensor and wearable technologies to reduce patient fatigue and capture more objective data.
TORONTO, April 19, 2023 /PRNewswire-PRWeb/ -- The adoption of hybrid decentralized clinical trial models is increasing in many therapeutic areas, and central nervous system (CNS) is topping the list: CNS studies represent roughly 26 percent of all DCTs conducted since 2015, according to GlobalData's Clinical Trial Database.
Within CNS, depression has emerged as a prime candidate for the successful deployment of hybrid DCT models. In this webinar, the featured speakers will address best practices and draw from their personal experiences, highlighting both the opportunities and the challenges of conducting depression clinical trials.
The convenience, discretion and regularity of reporting associated with remote participation can provide more accurate clinical outcomes while reducing burden on patients. A small, but growing, body of evidence also points to decentralized trials' facilitation of more truthful self-reporting on suicidality, which — when combined with remote patient monitoring — can make this method a potentially safer option for patients.
Yet many questions remain unanswered: How can study teams ensure that patients are being properly recruited, screened and consented into a decentralized study? How can remote participation be designed to benefit depression patients without jeopardizing data quality? Are the validated instruments commonly used in depression trials suitable for decentralized data collection? How is the placebo effect accounted for in decentralized study designs?
Register now to learn more about delivering stronger evidence in depression clinical trials.
Join Taylor Major, MBA MPH, Senior Implementation Project Manager, ObvioHealth; Jenny Ly, PhD, Senior Clinical Scientist, SPRIM Consultancy; and Faith Matcham, PhD, CPsychol, Health Psychologist and Lecturer in Clinical Psychology, University of Sussex, UK, for the live webinar on Tuesday, May 9, 2023, at 10am EDT (4pm CEST/EU-Central).
For more information, or to register for this event, visit Depression Clinical Trials: How Remote Methods Can Deliver Stronger Evidence.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
Share this article